PRKCB and liver dysplastic nodule: Recently, we showed that hyperglycemia can activate PKCβ isoforms, which enhance angiotensin II (Ang II) toxic effect in glomerular endothelial cells and decrease glucagon-like peptide-1 (GLP-1) receptor, leading to resistance of GLP-1's treatment on DN [10].